Paper Details

  1. Home
  2. Paper Details

Adverse effects of azacitidine: onset, duration, and treatment.

Author: Martínez-FrancésAntonio

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article discusses the use of azacitidine, a DNA methyltransferase inhibitor, in treating high-risk myelodysplastic syndromes. Azacitidine has improved survival in these patients, but requires careful management of side effects, primarily hematological and nonhematological.
Paper Details　
Original Abstract of the Article :
High-risk myelodysplastic syndromes present a poor prognosis, with survivals of close to only 1 year. The use of azacitidine, a DNA methyltransferase inhibitor, in this group of patients has transformed this grey image, with a demonstrated improvement in survival. Responses to survival are attained ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s12325-011-0021-5

データ提供：米国国立医学図書館（NLM）

Azacitidine: A New Weapon in the Battle Against Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are like a raging sandstorm in the body, disrupting the delicate balance of blood cell production. While these diseases often carry a grim prognosis, researchers are continually searching for new weapons to fight this battle, much like explorers searching for a safe haven in a fierce desert storm. This study, published in the journal 'Annals of Hematology,' explores the potential of azacitidine, a DNA methyltransferase inhibitor, in treating high-risk MDS.

A Desert Oasis: Azacitidine Offers Hope for High-Risk MDS

This study, like a shimmering oasis in the desert, reveals the promise of azacitidine in improving the survival rates of patients with high-risk MDS. The findings demonstrate the importance of continuous treatment with azacitidine, much like a traveler must stay on the path to reach their destination in the desert. However, careful management of the drug's adverse effects is crucial, much like a wise traveler preparing for a journey by ensuring they have the necessary provisions.

A New Dawn: Azacitidine Brings Hope and the Importance of Ongoing Research

This study offers a glimmer of hope for those battling high-risk MDS. The potential of azacitidine, while showing great promise, underscores the need for continued research and development to enhance its effectiveness and minimize its side effects. This research, like a guide through the desert, reminds us that the battle against MDS is ongoing, with new discoveries emerging that can improve the lives of patients.

Dr. Camel's Conclusion

Azacitidine stands as a beacon of hope in the battle against high-risk MDS. While the challenges of managing side effects remain, this study highlights the potential of this drug to significantly improve survival rates. The journey through the desert of MDS continues, and it is crucial that we continue to seek out new therapies and strategies to combat this formidable foe.
Date :
  1. Date Completed 2011-10-13
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21688206

DOI: Digital Object Identifier

10.1007/s12325-011-0021-5

Related Literature

Article Analysis
・Effects of azacitidine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.